Increased Expression of BRCA1 mRNA Predicts Favorable Response to Anthracycline-Containing Chemotherapy in Breast Cancers
- 1 March 2003
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 78 (1) , 45-50
- https://doi.org/10.1023/a:1022101310500
Abstract
Clinical significance of BRCA1 and BRCA2 mRNA levels in tumor tissues as predictors of response to anthracycline-containing chemotherapy was studied in breast cancer patients. Fifty-one patients with...Keywords
This publication has 23 references indexed in Scilit:
- Quantitative Analysis of BRCA1 and BRCA2 mRNA Expression in Sporadic Breast Carcinomas and Its Relationship with Clinicopathological CharacteristicsJapanese Journal of Cancer Research, 2001
- The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived MutationJournal of Biological Chemistry, 2001
- Overexpression of BRCA2 gene in sporadic breast tumoursOncogene, 1999
- Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancerOncogene, 1999
- EpirubicinDrugs & Aging, 1999
- Tumour biological features of BRCA1-induced breast and ovarian cancerEuropean Journal Of Cancer, 1997
- BRCA2 mutations in primary breast and ovarian cancersNature Genetics, 1996
- Mutation analysis in the BRCA2 gene in primary breast cancersNature Genetics, 1996
- Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13Science, 1994
- Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancersEuropean Journal Of Cancer, 1994